← Back to Patent Explorer
US5456662A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for reducing snoring by RF ablation of the uvula

Assignee: Somnus Medical Technologies Inc
•
Filing: 1994-05-09
•
Granted: 1995-10-10
•
Expires: 2014-05-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A medical ablation method for reducing snoring wherein a flexible RF electrode wire surrounded by an insulating sleeve axially moveable thereon is inserted into an uvula; the sleeve is retracted to expose a predetermined portion of the electrode; and RF energy is applied to the uvula tissue through the electrode to cause internal lesions in the uvula and reduce snoring.

Inventors

  • 👤 Stuart D. Edwards
  • 👤 David L. Douglass

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 02:22
CPC Classifications
A; A61; A61B; A61B10/00; A61B10/02; A61B10/0233; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1477; A61B18/1485; A61B18/18; A61B18/1815; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/06; A61N1/40; A61N1/403; A61N5/00; A61N5/02; A61N5/04; A61N5/045; A61B18/148; A61B18/20; A61B18/22; A61B18/24; A61B17/00; A61B2017/00017; A61B2017/00022; A61B2017/00084; A61B2017/00092; A61B2017/00101; A61B2017/00106; A61B2017/00115; A61B2017/00119; A61B2017/00123; A61B2017/00137; A61B2017/00154; A61B2017/00181; A61B2017/00194; A61B17/00234; A61B2017/00238; A61B2017/00274; A61B2017/00292; A61B2017/00296; A61B2017/003; A61B2017/00831; A61B2017/00867; A61B17/22; A61B2017/22072; A61B2017/22074; A61B2017/22077; A61B2017/22082; A61B17/24; A61B2017/248; A61B17/34; A61B2017/348; A61B2017/3482; A61B2017/3484; A61B2017/3488; A61B2018/00005; A61B2018/00011; A61B2018/00023; A61B2018/00053; A61B2018/00059; A61B2018/00071; A61B2018/00083; A61B2018/00089; A61B2018/00095; A61B2018/00101; A61B2018/00184; A61B2018/00196; A61B2018/00214; A61B2018/0022; A61B2018/00273; A61B2018/00291; A61B2018/00315; A61B2018/00321; A61B2018/00327; A61B2018/00547; A61B2018/00571; A61B2018/00577; A61B2018/00636; A61B2018/00666; A61B2018/00678; A61B2018/00696; A61B2018/00702; A61B2018/00726; A61B2018/00744; A61B2018/00761; A61B2018/00773; A61B2018/00791; A61B2018/00797; A61B2018/00821; A61B2018/00875; A61B2018/00886; A61B2018/0091; A61B2018/00916; A61B2018/0094; A61B2018/00946; A61B2018/00982; A61B18/1206; A61B2018/1246; A61B2018/1253; A61B2018/126; A61B2018/128; A61B2018/1405; A61B2018/1425; A61B2018/2238; A61B90/00; A61B90/08; A61B2090/0814; A61B90/36; A61B90/361; A61B2090/3614; A61B90/37; A61B2090/378; A61B2090/3782; A61B2090/3786; A61B90/39; A61B2090/3925; A61B2217/00; A61B2217/002; A61B2217/005; A61B2217/007; A61B2218/00; A61B2218/001; A61B2218/002; A61B2218/003; A61F; A61F7/00; A61F2007/0054; A61M; A61M25/00; A61M25/0067; A61M25/0082; A61M25/0084; A61M2025/0089; A61M2025/0096; A61M25/01; A61M2025/018; A61M25/0068

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 87 words
A method for medical ablation of tissue within a uvula to reduce snoring by reducing the size and mass of said uvula comprising the steps of: a) inserting a needle into said uvula, said needle having an electrode enclosed within an insulating sleeve axially moveable thereon and bendable therewith; b) retracting said sleeve from the terminus of the electrode to expose a predetermined electrode area for ablation; and d) applying RF energy to the tissue surrounding the exposed electrode area to effect ablation of said uvula tissue.
Claim 2
Independent Claim 87 words
A method for medical ablation of tissue within a uvula to reduce snoring by reducing the size and mass of said uvula comprising the steps of: a) inserting a needle into said uvula, said needle having an electrode enclosed within an insulating sleeve axially moveable thereon and bendable therewith; b) retracting said sleeve from the terminus of the electrode to expose a predetermined electrode area for ablation; and d) applying RF energy to the tissue surrounding the exposed electrode area to effect ablation of said uvula tissue.
Claim 3
Dependent Claim 168 words
An ablation treatment method for reducing the mass of cellular tissue of the uvula in order to reduce snoring comprising: a) introducing a cannula having a stylet lumen to the exterior of said uvula, the cannula having a distal end and a proximal end, the cannula having a control housing at its proximal end and an opening at its distal end, a flexible stylet with a sharp distal tip being enclosed within the stylet lumen of the cannula, the flexible stylet comprising an RF electrode having an insulating sleeve or coating extending along at least a portion thereof; b) extending the flexible stylet from the distal end of the cannula into the mass of cellular tissue of the uvula to be reduced; and c) passing RF current from the stylet through the mass of cellular tissue of the uvula to be reduced sufficient to raise the temperature of cells of the mass of cellular tissue of the uvula for a time sufficient to cause death of the cells.
Claim 4
Dependent Claim 168 words
An ablation treatment method for reducing the mass of cellular tissue of the uvula in order to reduce snoring comprising: a) introducing a cannula having a stylet lumen to the exterior of said uvula, the cannula having a distal end and a proximal end, the cannula having a control housing at its proximal end and an opening at its distal end, a flexible stylet with a sharp distal tip being enclosed within the stylet lumen of the cannula, the flexible stylet comprising an RF electrode having an insulating sleeve or coating extending along at least a portion thereof; b) extending the flexible stylet from the distal end of the cannula into the mass of cellular tissue of the uvula to be reduced; and c) passing RF current from the stylet through the mass of cellular tissue of the uvula to be reduced sufficient to raise the temperature of cells of the mass of cellular tissue of the uvula for a time sufficient to cause death of the cells.
Claim 5
Dependent Claim 148 words
The ablation treatment method of claim 2 for reducing the mass of the uvula wherein the stylet electrode has an insulating sleeve longitudinally slidable on the electrode, the method including the steps of a) extending the flexible stylet and insulating sleeve from the distal end of the cannula into the mass of cellular tissue of the uvula to be reduced, and retracting the sleeve or extending the electrode beyond the sleeve to expose a preselected length of electrode in the uvula, thereby control ling the length of the lesion to be obtained in the treatment; and c) passing RF current from the stylet through the mass of cellular tissue of the uvula to be reduced sufficient to raise the temperature of cells of the mass of cellular tissue of the uvula to be reduced to above 47° C. for a time sufficient to cause death of the cells.
Claim 6
Dependent Claim 159 words
An ablation treatment method for reducing the mass of cellular tissue of the uvula in order to reduce snoring comprising: a) introducing a cannula having a stylet lumen to the exterior of said uvula, the cannula having a distal end and a proximal end, the cannula having a control housing at its proximal end and an opening at its distal end, a flexible stylet with a sharp distal tip being enclosed within the stylet lumen of the cannula, the flexible stylet comprising a microwave antenna; b) extending the distal end of the microwave antenna from the distal end of the cannula into the mass of cellular tissue of the uvula to be reduced; and c) energizing the microwave antenna at a power and for a time sufficient to raise the temperature of cells of the mass of cellular tissue of the uvula to be reduced to above 47° C. for a time sufficient to cause death of the cells.
Claim 7
Dependent Claim 159 words
An ablation treatment method for reducing the mass of cellular tissue of the uvula in order to reduce snoring comprising: a) introducing a cannula having a stylet lumen to the exterior of said uvula, the cannula having a distal end and a proximal end, the cannula having a control housing at its proximal end and an opening at its distal end, a flexible stylet with a sharp distal tip being enclosed within the stylet lumen of the cannula, the flexible stylet comprising a microwave antenna; b) extending the distal end of the microwave antenna from the distal end of the cannula into the mass of cellular tissue of the uvula to be reduced; and c) energizing the microwave antenna at a power and for a time sufficient to raise the temperature of cells of the mass of cellular tissue of the uvula to be reduced to above 47° C. for a time sufficient to cause death of the cells.

References Cited (Backward Citations)

US32066A Cited
US1950788A Cited
US1879249A Cited
US1968997A Cited
US2022065A Cited
US2047535A Cited
US2008526A Cited
US2118631A Cited
US2710000A Cited
US3230957A Cited
US3339542A Cited
US3556079A Cited
US3682162A Cited
US3598108A Cited
US3595239A Cited
US3840016A Cited
US3884237A Cited
US3835842A Cited
US3850175A Cited
US3924628A Cited
US3828780A Cited
US3939840A Cited
US3942530A Cited
US3991770A Cited
US4011872A Cited
US3858577A Cited
US3948270A Cited
US4119102A Cited
US4121592A Cited
US4137920A Cited
US4312364A Cited
US4136566A Cited
US4154246A Cited
US4228809A Cited
US4224929A Cited
DE2848484C2 Cited
US4204549A Cited
US4237898A Cited
US4311154A Cited
US4402311A Cited
US4295467A Cited
US4448198A Cited
US4267828A Cited
US4311145A Cited
US4307720A Cited
US4375220A Cited
US4411266A Cited
US4565200A Cited
US4805616A Cited
US4562838A Cited
US4452236A Cited
US4397314A Cited
US4568329A Cited
US4470407A Cited
DE3218314C2 Cited
US4494539A Cited
US4405314A Cited
US4676258A Cited
US4774949A Cited
US4672962A Cited
US4601296A Cited
US4798215A Cited
US4612940A Cited
US4682596A Cited
US4781186A Cited
US4552554A Cited
US4697595A Cited
US4706681A Cited
US4800899A Cited
US4580551A Cited
US4817601A Cited
US4594074A Cited
US4660560A Cited
US4658836A Cited
US4669475A Cited
US4681122A Cited
US4785829A Cited
US4818954A Cited
US4776086A Cited
US4700716A Cited
US5057106A Cited
US4822333A Cited
US4813429A Cited
US4823812A Cited
US4709698A Cited
US4949706A Cited
US4872458A Cited
US4753223A Cited
US4940064A Cited
US4893623A Cited
US4946449A Cited
US4719914A Cited
US4765331A Cited
US5003991A Cited
US4823791A Cited
US4905667A Cited
US4943290A Cited
US4906230A Cited
US4769005A Cited
US4784638A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-10-09 1999-04-10 1999-10-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-10-09 2003-04-10 2003-10-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-10-09 2007-04-10 2007-10-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag